Novavax reported $15.44B in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamas Pharmaceuticals ADMS:US 223.88M 15.88M
Adma Biologics ADMA:US $ 150.03M 55.07M
Agenus AGEN:US $ 1.22B 2.65M
AstraZeneca AZN:LN 138.77B 24.78B
Astrazeneca AZN:US 186.95B 29.34B
Biocryst Pharmaceuticals BCRX:US $ 2.57B 239.02M
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Genocea Biosciences GNCA:US $ 109.47M 17.91M
Geron GERN:US $ 439.22M 9.96M
GlaxoSmithKline GSK:LN 70.63B 794.04M
Kindred Biosciences KIN:US $ 420.53M 198.33M
Mannkind MNKD:US $ 1.09B 274.39M
Merk MRK:US $ 190131.55M 6786.63M
Minerva Neurosciences NERV:US $ 74.34M 24.78M
Moderna Inc MRNA:US $ 155.35B 61B
Novartis NVS:US 200.79B 24.12B
Novavax NVAX:US $ 15.44B 289.68M
Pain Therapeutics PTIE:US $ 2.48B 934.23M
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Pfizer PFE:US $ 241143.67M 21937.97M
Sanofi SAN:FP 104.97B 6.43B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Tg Therapeutics TGTX:US $ 4.75B 757.38M